New injection shows promise for teen eczema relief
NCT ID NCT06277765
Summary
This study tested an investigational injection called CM310 to see if it could safely reduce the symptoms of moderate-to-severe eczema in teenagers. 180 participants were randomly assigned to receive either the real drug or a placebo (a dummy injection) for 18 weeks. Researchers measured how much the eczema cleared up and how much the itching improved.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Peking University People's hospital
Beijing, China
Conditions
Explore the condition pages connected to this study.